MIGs 2023

2023 Metabolic Interest Group (MIGs) Schedule

Running since 2009 the Metabolic Interest Group is a collection of labs at UVA that meet monthly to discuss research in progress pertaining to the broad area of metabolism. Meetings are held on the second Wednesday of each month at 4:00 PM in the Pharmacology library (Room 5023).

New for 2023: Only one lab will present a research in progress seminar each month.

The intent of this meeting is to provide students, postdocs, and faculty an opportunity to get feedback on current projects.

Month Presenting
January 11th Schulman Lab

Ira Schulman Presenting;

WTF: A Cure for NASH?

February 8th Civelek Lab

Jordan Reed presenting;

Nutrigenomics: The effects of diet and genetic background on multi-tissue metabolic response

March 8th  Harris Lab

Mike Lemke presenting;

Mast kinases. How do they work, and what do they do?

April 12th Ferris Lab

Heather Ferris presenting;

Inceptor, a novel regulator of insulin signaling

May 10th Bland Lab

Lizzie Van Gorder presenting;

PCYT1 regulation during infection and effects on lipidome and immune response in Drosophila”


June 14th Leitinger Lab

Clint Upchurch presenting;

Metabolism and oxidized phospholipids

July 12th Schulman Lab

Ira Schulman presenting;

Nuclear Receptor Structure and Function: Drug Discovery for the Unexplored Millennium (DUM)

August 9th Civelek Lab

Jordan Reed presenting;

Systems genetics analysis of human body fat distribution genes identify Wnt signaling and mitochondrial activity in adipocytes”

September 13th Ferris Lab

Joshua Milstein presenting;

“Regulation of Glial ApoE Secretion by Prenylation”

October 18th Harris Lab

Daniel Lank presenting;

A2BR in Adipose Tissue: A Bad Actor in the Regulation of Lipolysis

November 8th Bland Lab

Michelle Bland presenting;

Divergent responses of Drosophila insulin-like peptides to dietary sugar and protein

December 13th Leitinger Lab

Scott Yeudall presenting;

Macrophage PFKFB3 and glycolysis as regulators of heme-induced inflammation: implications for hemolytic disorders and sickle cell disease